Korean Drug Co

appearance

Pink, round, film-coated tablets

packaging unit

30T, 100T

insurance price

629

Insurance claim code

642801570

Quantity of drug substance

Clopidogrel sulfate (clopidogrel) 97.875 mg (75 mg)

Efficacy and effect

1. Improvement of atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial

disease Atherosclerotic symptoms (death due to cardiovascular disease, myocardial infarction, stroke, or refractory ischemia) in adult patients with or without stent procedure) 3. Reduction of

the risk of atherosclerosis and thromboembolism, including stroke, in adult patients with atrial fibrillation who have one or more vascular risk factors, are not suitable for vitamin K antagonist (VKA) administration, and have low bleeding risk

Usage and dosage

○ Adults

1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, clopidogrel 75 mg once a day is orally administered.

2. For patients with acute coronary syndrome (unstable angina pectoris or non-Q wave myocardial infarction), on the day of initiation of administration of this drug, 300 mg once a day as a loading dose, and thereafter, 1 day per day Administer orally as a maintenance dose of 75 mg each time. In this case, 75 ~ 325 mg of aspirin should be administered in combination with this drug once a day.

3. For patients with atrial fibrillation, take 75 mg orally once a day as this drug. In this case, 75 ~ 100 mg of aspirin should be administered in combination with this drug once a day.

○ Patients

with renal impairment: Treatment experience in patients with renal impairment is limited.

○ Patients with hepatic impairment

: Treatment experience is limited in patients with moderate liver disease with a bleeding constitution.

This drug can be administered regardless of food intake.

How to save

Airtight container, room temperature (1-30℃) storage

period of use

36 months from date of manufacture